Elliot McKerr

Canadian Pharma Company HYTN Inks Deal To Supply Medical Marijuana To UK, Eyes Germany And Australia Expansion

HYTN Innovations Acquires Prism Labs To Boost Psychedelic Drug Manufacturing Capabilities

HYTN Innovations Cultivates Psilocybin Mushrooms And Upgrades Equipment For API Development

HYTN Innovations Acquires Prism Labs To Boost Psychedelic Drug Manufacturing Capabilities

HYTN Innovations Cultivates Psilocybin Mushrooms And Upgrades Equipment For API Development

HYTN To Complement Cannabis Line With Psilocybin-Based Products, Obtains Controlled Drugs And Substances Dealer's License

HYTN Launches Nano Gummies Offering 'Faster And More Consistent Cannabis Experience'

HYTN To Complement Cannabis Line With Psilocybin-Based Products, Obtains Controlled Drugs And Substances Dealer's License

HYTN Launches Nano Gummies Offering 'Faster And More Consistent Cannabis Experience'

HYTN Awarded Medical Cannabis Sales License By Health Canada

HYTN Grows Exports With Cannabis Flower Sales To Australia

Elliot McKerr Recent News

HYTN Innovations To Accept Cannabis Orders Directly From Provinces & Territories

HYTN Innovations Inc. (CSE:HYTN) announced that it has begun accepting orders directly from Provincial buyers.

HYTN Innovations Receives Health Canada's Approval To Sell Cannabis

HYTN Innovations Inc.’s (CSE:HYTN) subsidiary HYTN Cannabis Inc., has awarded a license amendment by Health Canada allowing for the sale of cannabis extract, edible cannabis, and cannabis topical products to provincially and territorially authorized retailers.